I value being part of the largest and fastest growing user community of its kind in the world
Instem Client
Instem Announces $2.6 Million Stimulus Package for PreClinical IT Market
Investment Aimed at New Users of Provantis™ Served over the Web – Applications To Be Accepted Through August 31, 2009
CONSHOHOCKEN, PA - (BUSINESS WIRE) - February 24, 2009 - - Instem, a leading provider of early drug development software solutions, announced today a $2,600,000 Stimulus Package for PreClinical Laboratories in all of its markets.
This aggressive move will enable organizations to subscribe to the Provantis™ PreClinical solution Online during 2009 at a fraction of the cost, delaying the majority of normal subscription fees for at least 12 months for up to 25 users per organization. Instem is not requiring any long-term commitments and the investment is reserved for new clients of Instem.
“Prospective clients find themselves in a classic ‘catch 22 situation’, they tell us they need to deploy Provantis™ to meet operational efficiency improvement targets or, as a CRO to meet sponsor expectations, but their capital and operational budgets are {quite rightly} being tightly controlled during 2009,” comments Phil Reason, CEO at Instem.
Organizations can apply for the program through Monday, August 31, 2009.
“As the leader in the PreClinical IT market, Instem has the unique ability to make a real difference for companies with this investment package and enable them to more easily experience the powerful benefits of Provantis™,” states Gary Mitchell, VP Global Marketing at Instem. “We have a comprehensive outreach campaign planned and we are expecting a strong response.”
For complete program details, please contact stimulus@instem.com
About Provantis
Provantis™ is a modern, fully integrated software system for single users and global organizations engaged in non-clinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis™ streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within a GLP or non-GLP environment.
GLP Compliancy & Beyond…
Trusted by more users at more sites, Provantis Online goes beyond GLP compliancy. Unlike competing vendors, Instem serves its application from an environment that offers the highest levels of security and performance, one that is military-grade and used by all of the leading pharmaceutical and life sciences companies listed in the Forbes Global 500.
Launched in 2005, Instem’s Online, or SaaS (Software-as-a-Service) model has set the standard for Web delivery and is now used for GLP and non-GLP studies from North America to Australia by clients of all sizes.
About Instem
Instem is a world-leading information solutions provider for the Life Sciences – accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of Business Intelligence, Planning, Workflow Management, Dosage Formulation, Document Management and Report Compilation applications.
Operating in a highly fragmented Life Sciences IT market, Instem is one of very few organizations that have developed the financial strength necessary to maintain a global leadership position with established products, while introducing new applications that can deliver the improvements in productivity that clients are aggressively pursuing.
Press Contact:
Instem
Automate. Accelerate. Discover.
Gary E. Mitchell
Tel: 610.941.0990
Email: gary.mitchell@instem.com
Links
Accessibility
Contact Us
© 2001 - 2010 Instem - All rights reserved